Catheter ablation in grown-up congenital heart disease patients: A single-center experience
- PMID: 39712280
- PMCID: PMC11657846
- DOI: 10.1016/j.ijcchd.2022.100326
Catheter ablation in grown-up congenital heart disease patients: A single-center experience
Abstract
Background: Supraventricular and ventricular tachyarrhythmias represent a common complication in grown-up patients with congenital heart defects (CHD) associated with worsening of functional capacity and increased morbidity. The aim of this study was to present the experience of our department on catheter ablation (CA) addressing safety and efficacy concerns.
Methods: Consecutive patients with CHD treated with CA between 2002 and 2021 in our hospital were included in this study. The established ablation techniques modified according to the patient's special anatomic characteristics were applied. NYHA functional status along with the underlying cardiac rhythm were recorded during the follow-up.
Results: In total, 35 patients (44.9 ± 2.7 years, 22 males) underwent CA for the management of either supraventricular or ventricular (n = 2) arrhythmia during the study period. The most common anatomical diagnoses were atrial septal defect (13), Tetralogy of Fallot (5) and transposition of great arteries (3). Atrial fibrillation or atrial flutter was the most frequent baseline diagnosis, observed in 15 (42.8%) patients, followed by intra-atrial reentrant tachycardia in 9 (25.7%) patients and atrioventricular nodal reentry tachycardia (AVNRT) in 5 (14.2%). No significant complication occurred during CA. Patients were followed for a median period of 9 years after the index procedure. At this time, arrhythmia recurrence was observed in 13 patients (37,1%) of whom 6 underwent a redo procedure. Furthermore, 4 patients underwent a permanent pacemaker implantation, while 6 were offered an ICD treatment.
Conclusion: CA is a safe method offering significant benefits regarding the management of tachyarrhythmias and preserving functional capacity in adult patients with CHD.
Keywords: Atrial tachycardia; Catheter ablation; Congenital heart disease; Supraventricular arrhythmias.
© 2022 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Role of radiofrequency ablation in the management of supraventricular arrhythmias: experience in 760 consecutive patients.J Cardiovasc Electrophysiol. 1993 Aug;4(4):371-89. doi: 10.1111/j.1540-8167.1993.tb01277.x. J Cardiovasc Electrophysiol. 1993. PMID: 8269306 Review.
-
Curing reentrant atrial arrhythmias. Targeting protected zones of slow conduction by catheter ablation.J Electrocardiol. 1993;26 Suppl:194-203. J Electrocardiol. 1993. PMID: 8189124
-
Catheter ablation for atrioventricular nodal reentrant tachycardia in patients with congenital heart disease.Heart Rhythm. 2016 Jun;13(6):1228-37. doi: 10.1016/j.hrthm.2016.01.020. Epub 2016 Jan 21. Heart Rhythm. 2016. PMID: 26804568
-
[Catheter ablation in supraventricular tachycardia].Z Kardiol. 1996;85 Suppl 6:45-60. Z Kardiol. 1996. PMID: 9064982 Review. German.
-
Radiofrequency catheter ablation of atrial arrhythmias. Results and mechanisms.Circulation. 1994 Mar;89(3):1074-89. doi: 10.1161/01.cir.89.3.1074. Circulation. 1994. PMID: 8124793
References
-
- Kaemmerer H., Bauer U., Pensl U., et al. Management of emergencies in adults with congenital cardiac disease. Am J Cardiol. 2008;101:521–525. - PubMed
-
- Bouchardy J., Therrien J., Pilote L., et al. Atrial arrhythmias in adults with congenital heart disease. Circulation. 2009;120:1679–1686. - PubMed
-
- Baumgartner H., De Backer J., V Babu-Narayan S., et al. ESC Guidelines for the management of adult congenital heart disease. Eur Heart J. 2020;2020:1–83. - PubMed
LinkOut - more resources
Full Text Sources